Companies / Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc.
ITCICIK 1567514
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Mates Sharon CEO | Other Sold to issuer | Common Stock | $124.77M | -945K -100.00% | 0 | low |
| Apr 2, 2025 | Mates Sharon CEO | Other Sold to issuer | Common Stock | $25.08M | -190K -100.00% | 0 | low |
| Apr 2, 2025 | Riggs Rory B Director | Other Sold to issuer | Common Stock | $17.36M | -132K -100.00% | 0 | low |
| Mar 11, 2015 | Alafi Christopher D Director | Buy Open-market buy | Common Stock | $15.00M | +625K +24001.54% | 627,604 | high |
| Apr 2, 2025 | Neumann Mark Executive | Other Sold to issuer | Common Stock | $6.97M | -53K -100.00% | 0 | low |
| Mar 17, 2022 | Riggs Rory B Director | Sell Open-market sale | Common Stock | $6.94M | -115K -84.78% | 20,637 | medium |
| Apr 2, 2025 | Marcus Joel S Director | Other Sold to issuer | Common Stock | $6.37M | -48K -100.00% | 0 | low |
| Mar 11, 2015 | Sosland Morton I. 10% owner | Buy Open-market buy | Common Stock | $6.00M | +250K +12.83% | 2,198,554 | high |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ITCI | common | 46116X101 |